Public market access to revolutionary medical innovation
Arix Bioscience plc (LSE: ARIX) is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting edge advances in life sciences. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
Our main goals are to make a difference to patients' lives and generate a superior return for our investors.
Latest Presentation
Annual Report and Accounts
For the year ended 31st Dec 2022
NAV (at 30 June 2023)
NAV per share (at 30 June 2023)
Cash (at 30 June 2023)
GPV (at 30 June 2023)
LON:ARIX